N/A
Manufactured by Bionpharma Inc.
10,217 FDA adverse event reports analyzed
Last updated: 2026-04-15
AMANTADINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bionpharma Inc.. The most commonly reported adverse reactions for AMANTADINE HYDROCHLORIDE include FALL, FATIGUE, GAIT DISTURBANCE, DRUG INEFFECTIVE, HALLUCINATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMANTADINE HYDROCHLORIDE.
Out of 4,758 classified reports for AMANTADINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 10,217 FDA FAERS reports that mention AMANTADINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FALL, FATIGUE, GAIT DISTURBANCE, DRUG INEFFECTIVE, HALLUCINATION, TREMOR. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Bionpharma Inc. in connection with AMANTADINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.